The Clinical Outcome of Hurler Syndrome after Stem Cell Transplantation
Open accessThe DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Hurler syndrome (HS) is a severe inborn error of metabolism causing progressive multi-system morbidity and death in early childhood. At present, stem cell transplantation (SCT) is the only available treatment that can prevent central nervous system disease progression in HS patients. Although SCT has been shown to be effective for several important clinical outcome parameters, the reported clinical outcome after successful SCT is variable among HS patients and there are still some major limitations. This review will focus on the clinical outcome of HS patients after successful SCT, with particular emphasis on the long-term outcome and complications. In addition, factors that are suggested to contribute to the variable outcome are outlined, as well as the limitations of SCT in HS patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Screening for Disease.
(1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-5-1085_2 · Cited by 3,066
Prevalence of lysosomal storage disorders
Meikle, P. J. (1999) · JAMA · doi:10.1001/jama.281.3.249 · Cited by 2,197 · cited 1×
“Furthermore, since lysosomal storage disorders have a combined incidence of around 1:7700 (even up to 1:5000 when all lysosomal storage disorders are considered) [ 116 ], (which is twice as prevalent as phenylketonuria), the simultaneous detection of multiple, treatable lysosomal storage disorders combined in one neon…”
BackgroundKögler, G., Sensken, S., Airey, J. A., Trapp, T., Müschen, M., Feldhahn, N., Liedtke, S., Sorg, R. V., Fischer, J., Rosenbaum, C., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040440 · Cited by 1,029 · cited 1×
“... the higher level of human leukocyte antigen incompatibility, lower rates of acute and chronic graft-versus-host disease (aGVHD, cGVHD) are reported [51,90,94]; 4) The likelihood of transmitting (viral) infections is reduced [94,95]; and 5) Although highly speculative, there are suggestions of trans-differentiation…”
BackgroundKurtzberg, J., Laughlin, M., Graham, M. L., Smith, C., Olson, J. F., Halperin, E. C., Ciocci, G., Carrier, C., Stevens, C. E., & Rubinstein, P. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607183350303 · Cited by 1,024
Transplantation of Umbilical-Cord Blood in Babies with Infantile Krabbe's Disease
Escolar, M. L., Poe, M. D., Provenzale, J. M., Richards, K. C., Allison, J., Wood, S., Wenger, D. A., Pietryga, D., Wall, D., Champagne, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042604 · Cited by 709 · cited 3×
“Furthermore, the use of CB for SCT has several other important advantages compared to other stem cellsources(BM,PB),including:1)Cordbloodisreadilyavailable(oftenwithinamonth),significantlyreducing the time between diagnosis and SCT [51, 91 ,93].”
BackgroundInfluentialEnzyme-Replacement Therapy in Mucopolysaccharidosis I
Kakkis, E. D., Muenzer, J., Tiller, G. E., Waber, L., Belmont, J., Passage, M., Izykowski, B., Phillips, J., Doroshow, R., Walot, I., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101183440304 · Cited by 667
Koç, O., Day, J., Nieder, M., Gerson, S., Lazarus, H., & Krivit, W. (2002) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703650 · Cited by 652
Wraith, J. E., Clarke, L. A., Beck, M., Kolodny, E. H., Pastores, G. M., Muenzer, J., Rapoport, D. M., Berger, K. I., Swiedler, S. J., Kakkis, E. D., et al. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.01.046 · Cited by 547
HOBBS, J. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91046-1 · Cited by 488
Cord-Blood Transplants from Unrelated Donors in Patients with Hurler's Syndrome
Staba, S. L., Escolar, M. L., Poe, M., Kim, Y., Martin, P. L., Szabolcs, P., Allison-Thacker, J., Wood, S., Wenger, D. A., Rubinstein, P., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032613 · Cited by 478
Cumulative incidence rates of the mucopolysaccharidoses in Germany
Baehner, F., Schmiedeskamp, C., Krummenauer, F., Miebach, E., Bajbouj, M., Whybra, C., Kohlschütter, A., Kampmann, C., & Beck, M. (2005) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-005-0112-z · Cited by 435
DOUBLE-BLIND COMPARISON OF CAPTOPRIL ALONE AGAINST FRUSEMIDE PLUS AMILORIDE IN MILD HEART FAILURE
Richardson, A., Scriven, A. J., Poole-Wilson, P. A., Bayliss, J., Parameshwar, J., & Sutton, G. C. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91074-9 · Cited by 433
Waisbren, S. E. (2003) · JAMA · doi:10.1001/jama.290.19.2564 · Cited by 360 · cited 2×
“This is probably due to reduced organ damage pre-SCT and fewer cases of viral reactivations after transplantation; 2) The possibility of genetic counseling for the parents of an affected child, to provide the option of prenatal diagnosis or pre-implantation genetic diagnosis for subsequent pregnancies; and 3) Avoidanc…”
BackgroundKennedy, D. W., & Abkowitz, J. L. (1997) · Blood · doi:10.1182/blood.v90.3.986 · Cited by 342
Peters, C., Shapiro, E. G., Anderson, J., Henslee-Downey, P. J., Klemperer, M. R., Cowan, M. J., Saunders, E. F., deAlarcon, P. A., Twist, C., Nachman, J. B., et al. (1998) · Blood · doi:10.1182/blood.v91.7.2601 · Cited by 342
Direct Multiplex Assay of Lysosomal Enzymes in Dried Blood Spots for Newborn Screening
Li, Y., Scott, C. R., Chamoles, N. A., Ghavami, A., Pinto, B. M., Turecek, F., & Gelb, M. H. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.035907 · Cited by 332 · cited 1×
“Although it is already technically possible to diagnose HS using dried blood spots [12,117, 118 ], demonstration of a significant medical benefit due to early diagnosis is mandatory before such a newborn screeningfor HScanbeimplemented[119].Tomeetthiscriterion, an international observational study evaluating the long-…”
BackgroundOutcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome
Peters, C., Balthazor, M., Shapiro, E., King, R., Kollman, C., Hegland, J., Henslee- Downey, J., Trigg, M., Cowan, M., Sanders, J., et al. (1996) · Blood · doi:10.1182/blood.v87.11.4894.bloodjournal87114894 · Cited by 315 · cited 13×
“Significant correlations, between the age at SCT and the slope of the cognitive development after SCT (-0.64; P\.03 and -0.51; P5.01), as well as the baseline Mental Development Index (MDI) and slope of the cognitive development after SCT (0.76; P\.05 and 0.77; P5.0002), have been documented in HS patients and support…”
BackgroundResultInfluentialVellodi, A. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05293.x · Cited by 295 · cited 2×
“Although it is not clear what level of microglial engraftment is required to arrest CNS disease progression in HS patients, the significantly slower rate of CNS microglia repopulation (especially at parenchymal sites [100]) might account for the disease progression in the immediate post-transplantation period [ 8 ,100…”
BackgroundKrivit, W., Peters, C., & Shapiro, E. G. (1999) · Current Opinion in Neurology · doi:10.1097/00019052-199904000-00007 · Cited by 273
Allogeneic bone marrow transplantation for lysosomal storage diseases
Hoogerbrugge, P. M., Brouwer, O. F., Bordigoni, P., Cornu, G., Kapaun, P., Ortega, J. J., O'Meara, A., Souillet, G., Frappaz, D., Blanche, S., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92597-x · Cited by 256
Wraith, J. E., Beck, M., Lane, R., van der Ploeg, A., Shapiro, E., Xue, Y., Kakkis, E. D., & Guffon, N. (2007) · Pediatrics · doi:10.1542/peds.2006-2156 · Cited by 249
Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation
Shapiro, E. G., Lockman, L. A., Balthazor, M., & Krivit, W. (1995) · Journal of Inherited Metabolic Disease · doi:10.1007/bf00710053 · Cited by 245
Koç, O. N., Peters, C., Aubourg, P., Raghavan, S., Dyhouse, S., DeGasperi, R., Kolodny, E. H., BenYoseph, Y., Gerson, S. L., Lazarus, H. M., et al. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00101-0 · Cited by 235
Meier, C., Middelanis, J., Wasielewski, B., Neuhoff, S., Roth-Haerer, A., Gantert, M., Dinse, H. R., Dermietzel, R., & Jensen, A. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000197309.08852.f5 · Cited by 235 · cited 1×
“... the higher level of human leukocyte antigen incompatibility, lower rates of acute and chronic graft-versus-host disease (aGVHD, cGVHD) are reported [51,90,94]; 4) The likelihood of transmitting (viral) infections is reduced [94,95]; and 5) Although highly speculative, there are suggestions of trans-differentiation…”
BackgroundPastores, G. M., Arn, P. H., Beck, M., Clarke, J. T. R., Guffon, N., Kaplan, P. B., Muenzer, J., Norato, D., Shapiro, E., Thomas, J. A., et al. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.01.011 · Cited by 232
Incidence of the mucopolysaccharidoses in Northern Ireland
Nelson, J. (1997) · Human Genetics · doi:10.1007/s004390050641 · Cited by 229
Boelens, J. J., Wynn, R. F., O'Meara, A., Veys, P., Bertrand, Y., Souillet, G., Wraith, J. E., Fischer, A., Cavazzana-Calvo, M., Sykora, K. W., et al. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705718 · Cited by 212
Self-citationKrivit, W. (1995) · Cell Transplantation · doi:10.1016/0963-6897(95)00021-o · Cited by 208
Souillet, G., Guffon, N., Maire, I., Pujol, M., Taylor, P., Sevin, F., Bleyzac, N., Mulier, C., Durin, A., Kebaili, K., et al. (2003) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704105 · Cited by 208
Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres
Vellodi, A., Young, E. P., Cooper, A., Wraith, J. E., WINCHESTER, B. G., Meaney, C., Ramaswami, U., & Will, A. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.76.2.92 · Cited by 204
Beck, M. (2007) · Human Genetics · doi:10.1007/s00439-006-0280-4 · Cited by 199
Storage solutions: treating lysosomal disorders of the brain
Jeyakumar, M., Dwek, R. A., Butters, T. D., & Platt, F. M. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1725 · Cited by 192 · cited 1×
“As the nondegraded GAGs accumulate, the number, as well as the volume, of the lysosomes increases, eventually causing mechanical and chemical disruption of the cell [ 7 ].”
BackgroundLong‐term outcome of Hurler syndrome following bone marrow transplantation
Whitley, C. B., Belani, K. G., Chang, P., Summers, C. G., Blazar, B. R., Tsai, M. Y., Latchaw, R. E., Ramsay, N. K. C., & Kersey, J. H. (1993) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320460222 · Cited by 189
Secondary accumulation of gangliosides in lysosomal storage disorders
WALKLEY, S. (2004) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2004.03.002 · Cited by 189
Martin, P. L., Carter, S. L., Kernan, N. A., Sahdev, I., Wall, D., Pietryga, D., Wagner, J. E., & Kurtzberg, J. (2006) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2005.09.016 · Cited by 188
Fratantoni, J. C., Hall, C. W., & Neufeld, E. F. (1969) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.64.1.360 · Cited by 175
Terlato, N. J., & Cox, G. F. (2003) · Genetics in Medicine · doi:10.1097/01.gim.0000078027.83236.49 · Cited by 167
Chamoles, N., Blanco, M. B., Gaggioli, D., & Casentini, C. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.12.2098 · Cited by 164 · cited 2×
“Although it is already technically possible to diagnose HS using dried blood spots [ 12 ,117,118], demonstration of a significant medical benefit due to early diagnosis is mandatory before such a newborn screeningfor HScanbeimplemented[119].Tomeetthiscriterion, an international observational study evaluating the long-…”
BackgroundKrivit, W., Lockman, L. A., Watkins, P. A., Hirsch, J., & Shapiro, E. G. (1995) · Journal of Inherited Metabolic Disease · doi:10.1007/bf00710052 · Cited by 160
Induced Degradation of Glycosaminoglycans in Hurler's and Hunter's Syndromes by Plasma Infusion
Ferrante, N. D., Nichols, B. L., Donnelly, P. V., Neri, G., Hrgovcic, R., & Berglund, R. K. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.2.303 · Cited by 159
Gene therapy for lysosomal storage diseases: the lessons and promise of animal models
Ellinwood, N. M., Vite, C. H., & Haskins, M. E. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.581 · Cited by 147
Wraith, J. E. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.3.489 · Cited by 147
Weisstein, J. S., Delgado, E. D., Steinbach, L. S., Hart, K., & Packman, S. (2004) · Journal of Pediatric Orthopaedics · doi:10.1097/01241398-200401000-00019 · Cited by 145
Follow-up of nine patients with Hurler syndrome after bone marrow transplantation
Guffon, N., Souillet, G., Maire, I., Straczek, J., & Guibaud, P. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70201-x · Cited by 143
Respiratory Complications of Mucopolysaccharide Storage Disorders
Semenza, G. L., & Pyeritz, R. E. (1988) · Medicine · doi:10.1097/00005792-198807000-00002 · Cited by 140
Tolar, J., Grewal, S., Bjoraker, K., Whitley, C. B., Shapiro, E., Charnas, L. R., & Orchard, P. J. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705934 · Cited by 134
Weisstein, J. S., Delgado, E. D., Steinbach, L. S., Hart, K., & Packman, S. (2003) · Journal of Pediatric Orthopaedics · doi:10.1097/00004694-200401000-00019 · Cited by 131
Bunge, S., Kleijer, W. J., Steglich, C., Beck, M., Zuther, C., Morris, C. P., SCHWINGER, E., Hopwood, J. J., Scott, H. S., & Gal, A. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.6.861 · Cited by 129
Meaney, C., Greenland, G., Adams, V., Vellodi, A., Young, E. P., WINCHESTER, B. G., & Beesley, C. E. (2001) · Human Genetics · doi:10.1007/s004390100606 · Cited by 127
Disordered breathing during sleep in patients with mucopolysaccharidoses
Leighton, S. E. J., Papsin, B. C., Vellodi, A., Dinwiddie, R., & Lane, R. (2001) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/s0165-5876(01)00417-7 · Cited by 124
Human Umbilical Cord Blood Progenitors: The Potential of These Hematopoietic Cells to Become Neural
Chen, N., Hudson, J. E., Walczak, P., Misiuta, I. E., Garbuzova-Davis, S. N., Jiang, L., Sanchez‐Ramos, J., Sanberg, P. R., Zigova, T., & Willing, A. E. (2005) · Stem Cells · doi:10.1634/stemcells.2004-0284 · Cited by 122
Trends in haematopoietic cell transplantation for inborn errors of metabolism
Boelens, J. J. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-005-0258-8 · Cited by 111 · cited 1×
“... for the rapidly progressive CNS involvement in HS patients; 2) Donors with alargernumberofhumanleukocyteantigendisparities can be used, increasing the possibility of finding a suitable donor [51,94]; 3) Despite the higher level of human leukocyte antigen incompatibility, lower rates of acute and chronic graft-vers…”
BackgroundSelf-citationUsefulness of bone marrow transplantation in the Hurler syndrome
Braunlin, E., Stauffer, N., Peters, C. H., Bass, J. L., Berry, J. M., Hopwood, J. J., & Krivit, W. A. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00909-3 · Cited by 109
Kachur, E., & Maestro, R. F. D. (2000) · Neurosurgery · doi:10.1097/00006123-200007000-00046 · Cited by 107
Cox‐Brinkman, J., Boelens, J. J., Wraith, J. E., O’Meara, A., Veys, P. A., Wijburg, F. A., Wulffraat, N. M., & Wynn, R. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705401 · Cited by 103
Self-citationLimitations of enzyme replacement therapy: Current and future
Wraith, J. E. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0239-6 · Cited by 101
Meikle, P. J., Brooks, D. A., Ravenscroft, E. M., Yan, M., Williams, R. E., Jaunzems, A. E., Chataway, T. K., Karageorgos, L. E., Davey, R. C., Boulter, C. D., et al. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.8.1325 · Cited by 100
Pastores, G. M., & Meere, P. A. (2004) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000147283.40529.13 · Cited by 94
Optic Nerve Head Swelling and Optic Atrophy in the Systemic Mucopolysaccharides
Collins, M. L. Z., Traboulsi, E. I., & Maumenee, I. H. (1990) · Ophthalmology · doi:10.1016/s0161-6420(90)32400-4 · Cited by 93
Grewal, S. S., Wynn, R., Abdenur, J. E., Burton, B. K., Gharib, M. I., Haase, C., Hayashi, R. J., Shenoy, S. S., Sillence, D. O., Tiller, G. E., et al. (2005) · Genetics in Medicine · doi:10.1097/01.gim.0000154299.22120.6a · Cited by 93
Long-term effects of bone marrow transplantation in dogs with mucopolysaccharidosis I.
Breider, M. A., Shull, R. M., & Constantopoulos, G. (1989) · Europe PMC (PubMed Central) · Cited by 82
Shull, R. M., Hastings, N. E., Selcer, R. R., Jones, J. B., Smith, J. R. L., Cullen, W. C., & Constantopoulos, G. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112830 · Cited by 82
Stem Cell Transplantation (Cord Blood Transplants)
Chao, N. J. A., Emerson, S. G., & Weinberg, K. I. (2004) · Hematology · doi:10.1182/asheducation-2004.1.354 · Cited by 81 · cited 2×
“Furthermore, the use of CB for SCT has several other important advantages compared to other stem cellsources(BM,PB),including:1)Cordbloodisreadilyavailable(oftenwithinamonth),significantlyreducing the time between diagnosis and SCT [51,91, 93 ].”
BackgroundSuccessful treatment of Wolman disease by unrelated umbilical cord blood transplantation
Stein, J., Garty, B. Z., Dror, Y., Fenig, E., Zeigler, M., & Yaniv, I. (2006) · European Journal of Pediatrics · doi:10.1007/s00431-006-0298-6 · Cited by 81
Constantopoulos, G., & Dekaban, A. S. (1978) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1978.tb12388.x · Cited by 76
Carpal tunnel syndrome in the mucopolysaccharidoses and related disorders.
Wraith, J. E., & Alani, S. M. (1990) · Archives of Disease in Childhood · doi:10.1136/adc.65.9.962 · Cited by 74
Ocular Changes in the Mucopolysaccharidoses after Bone Marrow Transplantation
Summers, C. G., Purple, R. L., Krivit, W. A., Pineda, R., Copland, G. T., Ramsay, N. K. C., Kersey, J. H., & Whitley, C. B. (1989) · Ophthalmology · doi:10.1016/s0161-6420(89)32795-3 · Cited by 66
Constantopoulos, G., Iqbal, K., & Dekaban, A. S. (1980) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1980.tb11220.x · Cited by 63
Church, H. J., Tylee, K. L., Cooper, A., Thornley, M., Mercer, J., Wraith, E., Carr, T. F., O’Meara, A., & Wynn, R. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705569 · Cited by 62
Chung, S., Ma, X., Liu, Y., Lee, D. C., Tittiger, M. E., & Ponder, K. P. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.08.001 · Cited by 56
Khanna, G., Heest, A. E. V., Agel, J. A., Bjoraker, K., Grewal, S., Abel, S., Krivit, W. A., Peters, C., & Orchard, P. J. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705586 · Cited by 46
Tokić, V., Barišić, I., Huzjak, N., Petković, G., Fumić, K., & Paschke, E. (2006) · European Journal of Pediatrics · doi:10.1007/s00431-006-0316-8 · Cited by 45
Long-Term Neurological Effects of Bone Marrow Transplantation in a Canine Lysosomal Storage Disease
Shull, R. M., Breider, M. A., & Constantopoulos, G. (1988) · Pediatric Research · doi:10.1203/00006450-198809000-00015 · Cited by 39
α-L-Iduronidase and enzyme replacement therapy for mucopolysaccharidosis I
Brooks, D. A. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.8.967 · Cited by 28
Bone marrow transplantation for feline mucopolysaccharidosis I
Ellinwood, N. M., Colle, M.-A., Weil, M. A., Casal, M. L., Vite, C. H., Wiemelt, S. P., Hasson, C., O’Malley, T. M., He, X., Prociuk, U., et al. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.03.001 · Cited by 28
Outcome after three years of laronidase enzyme replacement therapy in a patient with Hurler syndrome
Thomas, J. A., Jacobs, S., Kierstein, J., et al. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0457-y · Cited by 23
Cited by
Aldenhoven, M., Wynn, R. F., Orchard, P. J., O’Meara, A., Veys, P., Fischer, A., Valayannopoulos, V., Neven, B., Rovelli, A., Prasad, V. K., et al. (2015) · Blood · doi:10.1182/blood-2014-11-608075 · Cited by 321
Self-citationMucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment
Giugliani, R., Federhen, A., Muñoz Rojas, M. V., Vieira, T., Artigalás, O., Lapagesse Pinto, L., Azevedo, A. C., Acosta, A., Bonfim, C., Lourenço, C. M., et al. (2010) · Genetics and Molecular Biology · doi:10.1590/s1415-47572010005000093 · Cited by 188
“The results of the transplants performed more recently show significant progress with this procedure and a survival rate of over 70% (Staba et al., 2004; Boelens et al., 2007; Aldenhoven et al., 2008; Prasad et al., 2008), however the rates obtained in the northern hemisphere cannot be automatically extended to Brazil…”
BackgroundInfluentialBoelens, J. J., Prasad, V. K., Tolar, J., Wynn, R. F., & Peters, C. (2010) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2009.11.004 · Cited by 109
Self-citationNeonatal systemic AAV induces tolerance to CNS gene therapy in MPS I dogs and nonhuman primates
Hinderer, C., Bell, P., Louboutin, J.-P., Zhu, Y., Yu, H., Lin, G., Choa, R., Gurda, B. L., Bagel, J., O'Donnell, P., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.99 · Cited by 85
Wang, D., Shukla, C., Liu, X., Schoeb, T. R., Clarke, L. A., Bedwell, D. M., & Keeling, K. M. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2009.08.002 · Cited by 62
Metadata
- Authors
- Aldenhoven, M., Boelens, J., & de Koning, T. J.
- Venue
- Biology of Blood and Marrow Transplantation
- Publisher
- Elsevier BV
- Published
- 2008-05
- Volume
- 14
- Issue
- 5
- Pages
- 485-498
- ISSN
- 1083-8791 (ISSN-L)
- OpenAlex
- W2089680458
- Cited by
- 178
- References
- 76
- FWCI
- 6.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.